- About
- Clinical trials
- News & FAQs
- Clinician information
- Contact the program
The Australian Parkinson's Mission (APM) is an innovative seven-year research program, combining clinical trials and biomarker technologies with breakthrough genomics for people living with Parkinson's disease.
We hope to identify and validate a precision medicine framework for treating and preventing Parkinson's disease.
The APM was conceived as an Australian-led international collaboration between the Garvan Institute of Medical Research, Shake It Up Australia Foundation, the University of Sydney, the Cure Parkinson’s Trust (UK), The Michael J. Fox Foundation (USA) and Parkinson’s Australia.
In 2019 the APM received $30 million in Federal funding from the Medical Research Future Fund (MRFF) to slow and stop the progression of Parkinson’s disease.
The Australian Parkinson's Mission is conducting a seven-year Australian clinical trials program using repurposed drugs (potentially disease modifying drugs that could slow, stop or reverse Parkinson’s progression), integrated with transformative research, to identify and fast-track effective treatments for people with Parkinson’s.
Clinical trial site locations
The Australian Parkinson’s Mission clinical trial (APM001) is open for participant enrolment and recruitment. To determine whether you are eligible to participate in the clinical trial, please contact the closest site in your state.
Site | Contact name | Address | Phone/email |
---|---|---|---|
St Vincent’s Hospital | Dr Stephen Tisch, Consultant Neurologist | St Vincent's Hospital 390 Victoria Street | |
Brain and Mind Centre (Camperdown) | Stacey West
| 94 Mallett Street Camperdown NSW 2050
| +61 (2) 9114 4172
|
The Alfred Hospital | PI: Professor Kelly Bertram Study Coordinators: | Alfred Hospital | 0428 839 787
|
Southern Neurology (Kogarah) | A/Prof Raymond Schwartz | 2/19 Kensington Street | +61 (2) 8566 1500 |
Gold Coast Hospital and Health Service | Dr Saman Heshmat | Gold Coast Hospital and Health Service | +61 (7) 5687 3893 |
Royal Adelaide Hospital | PI: Dr John Tillett | Level 9G 370 Royal Adelaide Hospital Port Road | |
John Hunter Hospital | PI: Dr Elizabeth Pepper, RN: Olivia Chisholm | 2 Lookout Road, New Lambton NSW 2305 | +61 (2) 4985 5442 |
Please note: some sites may have additional processes e.g. wearing a mask. Please contact the site directly for further information.
If you're interested in participating in the APM001 clinical trial, you will first have to undergo a screening process to determine if you qualify for the trial. Screening may begin over the phone with your closest site. When you contact the site to be screened, there may be a short wait. Please be patient during this time.
- If you would like more information on APM’s clinical trial please see the Participant Information Sheet.
News updates
Frequently asked questions
The APM research program uses repurposed drugs (potentially disease modifying drugs that could slow or stop Parkinson’s progression), integrated with genomics research. The APM aims to identify and fast track effective treatments to people with Parkinson’s. The APM program is running over seven years, with the recruitment for the clinical trial having begun in June 2020.
To register your interest with the APM today, simply complete the form below indicating the information you would like to learn more about.
Contact us
Email: info@theapm.org.au